Federal grants to Blood Cell Technologies LLC
Blood Cell Technologies LLC in East Setauket, New York received $2.8 million in federal grants from fiscal 2021 to 2025, across 3 awards. Its largest program was Cardiovascular Diseases Research, with $2.1 million. In fiscal 2025 it was awarded $400,000.
From USAspending.gov award records, updated October 31, 2026.
- Grants, FY 2021 to 2025$2.8 million
- Awards3
- Awarded in FY 2025$400,000
- Largest award$2.1 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 1 | $690,965 |
| FY 2022 | 1 | $763,993 |
| FY 2023 | 2 | $898,408 |
| FY 2024 | 0 | $0 |
| FY 2025 | 1 | $400,000 |
Programs that fund Blood Cell Technologies LLC
| Program | Awards | Amount |
|---|---|---|
| Cardiovascular Diseases Research | 1 | $2.1 million |
| Cancer Treatment Research | 2 | $685,200 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 3 | $2.8 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Optimization of biliverdin IX? Reductase redox inhibitors as novel reagents for enhancing platelet production - program director/principal investigator (last, first, middle): nesbitt, natasha m.. Project summary/abstract this phase II sbir proposal will support our ongoing drug discovery program des | Cardiovascular Diseases Research | August 6, 2021 | $2.1 million |
| Development of second generation blvrb inhibitors for treating chemotherapy induced thrombocytopenia - project summary chemotherapy-induced thrombocytopenia (CIT) is one of the main dose-limiting toxicities of myelosuppressive chemotherapy. Indeed, it is estimated that nearly 50% of chemotherapy pat | Cancer Treatment Research | August 25, 2025 | $400,000 |
| Development of a new class of blvrb-targeted redox therapeutics in breast cancer - summary enhanced metabolic and mitochondrial activity inherent in actively proliferating cancer cells generates an excessive amount of reactive oxygen species (ROS), associated with intracellular redox imbalance that | Cancer Treatment Research | September 14, 2023 | $285,200 |
Questions people ask
How much federal grant money does Blood Cell Technologies LLC get?
$2.8 million in 3 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Blood Cell Technologies LLC the most?
The Department of Health and Human Services, with $2.8 million in 3 awards.
What is Blood Cell Technologies LLC's largest federal grant?
$2.1 million under Cardiovascular Diseases Research, with its first action in the period on August 6, 2021. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Blood Cell Technologies LLC?
Its largest are Cardiovascular Diseases Research and Cancer Treatment Research.
Other grant recipients in East Setauket
Largest federal grant recipients in New York · Federal grants in New York